ASCVD Risk Detection
10-year cardiovascular disease risk estimation via smartphone camera
Company profile
Company profile
Binah.ai is a digital health technology company that has developed an award-winning, AI-powered video-based health monitoring platform. The company's Health Data Platform transforms camera-equipped devices like smartphones and tablets into comprehensive health monitoring tools, enabling users to measure a wide range of vital signs and wellness indicators in just 35-50 seconds by recording a video of their face. The technology is delivered as a Software Development Kit (SDK) that can be seamlessly integrated into existing applications and workflows across insurance, healthcare, and wellness industries. Binah.ai's solution measures vital signs including blood pressure, heart rate, and respiratory rate, as well as advanced cardiovascular insights such as cardiac workload, pulse pressure, and mean arterial pressure. The platform also provides health risk detection capabilities including high fasting glucose, high total cholesterol, low hemoglobin, heart age, and ASCVD risk assessment. The company's bloodless blood test technology can measure hemoglobin and hemoglobin A1C using only a smartphone camera. Binah.ai serves over 150 companies globally, helping businesses in insurance underwriting, wellness programs, telehealth, remote patient monitoring, and clinical trials. The company's mission is to bridge health gaps by blending technology, science, and humanity, making health monitoring accessible to everyone, everywhere. The technology runs on end-user devices with edge architecture, ensuring privacy and eliminating cloud dependency while supporting equitable access to care regardless of gender, skin tone, or location.
Company description Binah.ai official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded deployment with recorded integration context.
Recorded integration context: Datos Health platform, EMR/Electronic Medical Records, Polar Electro wearables.
Company milestones
Partnership with Polar Electro for continuous monitoring (2025-2026). comestai partnership achieved CE MDR Class 1 certification in Europe with GDPR-compliant cloud (January 2026). Blood pressure monitoring and bloodless blood tests (hemoglobin, HbA1c) launched. ASCVD risk detection feature released. Serving over 150 companies globally with millions of users.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
10-year cardiovascular disease risk estimation via smartphone camera
Standalone health and wellness check application
Mobile application for health data monitoring and sharing
AI-powered video-based health monitoring SDK for vital signs measurement via smartphone camera
Video-based blood pressure measurement in 35 seconds
Hemoglobin and HbA1c measurement via smartphone camera
Comprehensive wellness assessment feature
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
NCT05539612 · Sponsor · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
wellness programs
client engagement across insurance and wellness
client and patient satisfaction
reduction in manual questionnaires
healthcare triage efficiency
patient engagement in healthcare
Partnership to deliver CE MDR Class 1 certified and GDPR-compliant health monitoring solutions for European insurance and pharmaceutical sectors
Achieved CE Medical Device Regulation Class 1 certification and GDPR-compliant cloud storage for European market deployment
Enhanced remote care automation platform with video-based vital signs monitoring to enable providers to measure patient vitals remotely without wearables
Eliminated logistical and financial challenges of distributing wearables to patients while expanding provider capacity to serve larger patient populations
Providing medical professionals with vital signs monitoring tool for patient care and traveler health assessment
Provided priceless information to medical professionals while giving patients sense of trust and safety in their care
Integration of video-based vital signs monitoring into Kimi Screening application to support digitalization roadmap and add new health data source
Created powerful remote vital signs monitoring tool offering customers greater insight into health status
Touchless vital signs checks for aging Americans and their caregivers to make routine healthcare tasks easier
Made routine important healthcare tasks magically easy for aging Americans and overwhelmed caregivers
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Binah.ai's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.